Registration Dossier

Identification

Display Name:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
EC Number:
433-820-6
EC Name:
-
CAS Number:
118058-74-5
IUPAC Name:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

Total tonnage band

Total range:
Tonnage Data Confidential

NONS

Registered as:
NONS
Submitted:
Individual Submission

Publication dates

First published:
06-Jul-2012
Last modified:
26-Apr-2019

Chemical safety assessment

Performed for this substance:
NO

Compositions open all close all

Type:
legal entity composition of the substance


Registrants /Suppliers of the substance open all close all

Latest dossier received
Registrant / Supplier details 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
o Sanofi Aventis Deutschland GmbH Industriepark Höchst H 831 (Room A0472) z.Hd. Hr. Dr. Schwind 65926 Frankfurt am Main Germany

Administrative data open all close all

  • 01-0000017997-50-0001
  • 01-0000017997-50-0002
  • 01-0000017997-50-0003

Contact Persons responsible for the SDS